MMedXYNews
Ask AIHomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY News/Clinical Updates

Section

Clinical Updates

1,553 articles

Ask AI
All specialtiesClinical UpdatesnewsCardiologyOncologyDiabetes & Endocrinology

Latest updates

Clinical Updates

Return to Competition and Career Sustainability After Primary ACL Reconstruction in Football: Insights from Nationwide and Long-Term Studies

This review synthesizes evidence on return to competition and career sustainability after ACL reconstruction in football, highlighting variable return rates by competitive level, persistent long-term participation challenges, and multifacto

Oct 26, 2026
Clinical Updates

Striving for Equity in Cystic Fibrosis Research: Perspectives from Black and Hispanic/Latino(a) Individuals with CF

This review explores barriers and facilitators influencing research participation among Black and Hispanic/Latino(a) individuals with cystic fibrosis (CF), highlighting systemic inequities, racialized experiences, and community-centered sol

Oct 26, 2026
Clinical Updates

Quadriceps Strength Recovery Trajectories Following ACL Reconstruction: Associations with Preoperative Predictors but Not Clinical Outcomes

Quadriceps strength recovery after ACL reconstruction exhibits three distinct trajectories linked to preoperative strength and meniscectomy status, yet these trajectories do not correlate with postoperative clinical outcomes at one year.

Oct 26, 2026
Clinical Updates

Immunogenicity and Safety of Fractional 17DD Yellow Fever Vaccine Doses in Young Children: Evidence from a Phase 4 Randomised Trial in Uganda and Broader Context

Fractional doses (one-fifth and one-half) of 17DD yellow fever vaccine demonstrate non-inferior immunogenicity and comparable safety to full doses in children aged 9–23 months, supporting dose-sparing strategies during vaccine shortages.

Oct 25, 2026
Clinical Updates

Association of Tele-Critical Care Capability With Interhospital Transfers and Potentially Low-Value Transfers Among Critically Ill Medicare Beneficiaries: A Nationwide Evidence Synthesis

This review synthesizes evidence linking tele-critical care with interhospital transfer patterns and outcomes, highlighting improved transfer selection and reduced low-value transfers among critically ill Medicare patients.

Oct 25, 2026
Clinical Updates

Combining Midostaurin with Low-Dose Cytarabine and Venetoclax in Older Adults with Newly Diagnosed AML: Evidence and Implications from the INTERVENE Phase 2 Trial

The INTERVENE trial reveals that adding midostaurin to low-dose cytarabine and venetoclax is tolerable and improves FLT3-ITD clearance and survival in older AML patients with FLT3-ITD, addressing resistance in this high-risk subgroup.

Oct 25, 2026
Clinical Updates

Lonvoguran Ziclumeran: A Breakthrough In Vivo CRISPR Gene-Editing Therapy for Hereditary Angioedema

Lonvoguran ziclumeran, an in vivo CRISPR-based single-dose gene-editing therapy, significantly reduces hereditary angioedema attacks and demonstrates a favorable safety profile, marking a transformative advance in treatment.

Oct 24, 2026
Clinical Updates

Integrating Body Composition Metrics for Prognostication in Head and Neck Cancer Radiotherapy: Advances and Clinical Implications

Recent evidence highlights the prognostic significance of body composition metrics, including BMI, skeletal muscle mass, and adiposity distribution, in head and neck cancer radiotherapy outcomes. Automated 3D CT phenotyping refines risk str

Oct 22, 2026
Cardiology

Genotype and Arrhythmic Risk in Dilated Cardiomyopathy: An Integrative Review of Genetic Stratification and Clinical Implications

Genetic variants in dilated cardiomyopathy confer differential arrhythmic risks, independent of traditional clinical parameters. Integrating recent registry data and molecular studies enhances risk stratification and informs tailored manage

Oct 22, 2026
Clinical Updates

Cardiovascular Safety and Therapeutic Potential of Orforglipron Versus Insulin Glargine in Type 2 Diabetes with Elevated Cardiovascular Risk: Insights from the ACHIEVE-4 Phase 3 Trial

A comprehensive review of the ACHIEVE-4 trial confirms orforglipron’s cardiovascular safety non-inferior to insulin glargine in type 2 diabetes patients at elevated cardiovascular risk, highlighting its oral administration and safety

Oct 22, 2026
Clinical Updates

Associations Between Routine Vaccinations and the Risk of New-Onset Idiopathic Uveitis: Immune Modulation and Clinical Implications

This review synthesizes evidence linking routine vaccinations, including COVID-19 and herpes zoster vaccines, with reduced risk of new-onset idiopathic uveitis, highlighting immune mechanisms and clinical impacts.

Oct 22, 2026
Cardiology

Adoption of Outpatient Management of Acute Low-Risk Pulmonary Embolism: Evidence, Implementation, and Future Directions

This review synthesizes evidence supporting outpatient management of acute low-risk pulmonary embolism (PE), highlighting risk stratification tools, safety outcomes, and implementation strategies to enhance adoption in clinical practice.

Oct 20, 2026
Anesthesiology

Cannabis Use and Prolonged Opioid Utilization After Head and Neck Free Flap Reconstructive Surgery: A Clinical Evidence Synthesis

This review evaluates evidence linking perioperative cannabis use to prolonged opioid use and functional outcomes in head and neck cancer patients undergoing free flap reconstruction, emphasizing implications for pain management.

Oct 20, 2026
Clinical Updates

Global Incidence of All-Cause Dementia: A Comprehensive Meta-Analysis and Contemporary Insights

This review synthesizes global dementia incidence from the COSMIC consortium, highlighting variations by age, sex, and economic regions, with implications for prevention and resource planning, informed by recent meta-analyses on risk factor

Oct 20, 2026
Clinical Updates

Neoadjuvant Stereotactic Ablative Radiotherapy Prior to Inferior Vena Cava Thrombectomy in Renal Cell Carcinoma: A Synthesis of Emerging Phase 2 Evidence

This review synthesizes phase 2 trial data supporting neoadjuvant stereotactic ablative radiotherapy for RCC with IVC tumor thrombus, highlighting improved recurrence-free survival, acceptable safety, and biomarker insights that underscore

Oct 20, 2026
Clinical Updates

Isoflurane-Based Inhaled Sedation for Acute Hypoxemic Respiratory Failure: Insights from the SAVE-ICU Randomized Clinical Trial

This review critically examines the SAVE-ICU trial assessing isoflurane inhaled sedation versus intravenous sedation in mechanically ventilated adults with acute hypoxemic respiratory failure, highlighting implications for clinical practice

Oct 19, 2026
Clinical Updates

Evaluation of a Commercial Pediatric Sepsis Early Detection Alert in Emergency Departments: Efficacy, Equity, and Clinical Implications

This review synthesizes evidence evaluating the Epic Pediatric Sepsis Early Detection Model (PESM), highlighting its low sensitivity for early sepsis identification, disparities in performance across demographics, and implications for clini

Oct 19, 2026
Clinical Updates

GLP-1 Receptor Agonists and Psychiatric Acute-Care Outcomes in Schizophrenia with Type 2 Diabetes: Insights from Real-World EHR Data

This review synthesizes evidence on GLP-1 receptor agonist initiation impacting psychiatric hospitalisation and emergency visits in adults with schizophrenia and type 2 diabetes, highlighting metabolic and psychiatric interplay and therapeu

Oct 19, 2026
Clinical Updates

High-Frequency Chest Wall Oscillation in Acute Respiratory Failure With Bronchial Hypersecretion: Evidence Synthesis and Clinical Implications

This review synthesizes current evidence on high-frequency chest wall oscillation (HFCWO) for airway clearance in acute respiratory failure with bronchial hypersecretion, highlighting recent RCT findings, mechanistic insights, and future re

Oct 19, 2026
Clinical Updates

Trends in Spending on Corrective Lenses: An Evidence-Based Review on Expenditures, Barriers, and Policy Implications

Corrective lens spending affects nearly 20% of the US population, with half paying fully out-of-pocket, highlighting substantial financial burdens and access barriers. Evidence from clinical trials and epidemiologic studies underscores cost

Oct 19, 2026
Previous
10 / 25
1…89101112…25
Next

Most read

  1. 01Cardiology

    Physical Activity Trajectories Before and After Cardiovascular Disease: Insights from the CARDIA Study

Go deeper with MedXY AI

Explore the evidence behind the news.

Ask AI
MedXY briefing

Stay informed

Medical news and research updates, delivered to your inbox.